Elena Farè
Impact in
Papers in
- Co-authors
- Andrea Necchi (33 shared papers)Patrizia Giannatempo (29 shared papers)Daniele Raggi (28 shared papers)Roberto Salvioni (22 shared papers)Nicola Nicolai (21 shared papers)Davide Biasoni (19 shared papers)Silvia Stagni (19 shared papers)Mario Achille Catanzaro (19 shared papers)
- Journals
- Clinical Genitourinary Cancer (10 papers)Annals of Oncology (8 papers)The Journal of Urology (5 papers)European Urology (4 papers)Clinical Breast Cancer (1 paper)
- Partner nations
- ItalyUnited StatesBangladesh
In The Last Decade
Elena Farè
43 papers receiving 1.8k citations
Elena Farè's Hit Papers
Peers
Comparison fields: 5 of 61
- Surgery 1.4k
- Oncology 469
- Urology 105
- Pulmonary and Respiratory Medicine 253
- Rheumatology 86
Countries citing papers authored by Elena Farè
This map shows the geographic impact of Elena Farè's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Farè with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Farè more than expected).
Fields of papers citing papers by Elena Farè
This network shows the impact of papers produced by Elena Farè. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Farè. The network helps show where Elena Farè may publish in the future.
Co-authors
The 25 scholars most cited alongside Elena Farè, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study Hit paper breakdown → | 2018 | 552 |
| 2 | Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies Hit paper breakdown → | 2019 | 264 |
| 3 | 2020 | 136 | |
| 4 | 2019 | 87 | |
| 5 | 2014 | 63 | |
| 6 | 2018 | 59 | |
| 7 | 2015 | 51 | |
| 8 | 2014 | 48 | |
| 9 | 2015 | 45 | |
| 10 | 2020 | 37 | |
| 11 | 2020 | 36 | |
| 12 | 2013 | 32 | |
| 13 | 2013 | 30 | |
| 14 | 2019 | 27 | |
| 15 | 2020 | 25 | |
| 16 | 2014 | 23 | |
| 17 | 2016 | 21 | |
| 18 | 2014 | 20 | |
| 19 | 2024 | 20 | |
| 20 | 2014 | 19 |
About Elena Farè
Elena Farè is a scholar working on Surgery, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Rheumatology, having authored 46 papers that have together received 1.8k indexed citations. Recurring topics across this work include Testicular diseases and treatments (21 papers), Bladder and Urothelial Cancer Treatments (20 papers), Cancer Immunotherapy and Biomarkers (6 papers), Sarcoma Diagnosis and Treatment (3 papers), Urinary and Genital Oncology Studies (3 papers), Neuroblastoma Research and Treatments (2 papers), Urologic and reproductive health conditions (2 papers) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Surgery (1.4k citations), Oncology (469 citations), Urology (105 citations), Pulmonary and Respiratory Medicine (253 citations) and Rheumatology (86 citations). Elena Farè has collaborated with scholars based in Italy, United States and Bangladesh. Frequent co-authors include Andrea Necchi, Patrizia Giannatempo, Daniele Raggi, Roberto Salvioni, Nicola Nicolai, Davide Biasoni, Silvia Stagni, Mario Achille Catanzaro, Luigi Piva and Tullio Torelli. Their work appears in journals such as Clinical Genitourinary Cancer, Annals of Oncology, The Journal of Urology, European Urology and Clinical Breast Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.